Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chang Zou

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Molecular Cancer|October 9, 2020
Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencingXiaoshi Ma, Jinan Guo, Kaisheng Liu, et al.
Molecular Cancer|July 19, 2017
FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancerShucai Yang, Yi Liu, Ming-Yue Li, et al.
Frontiers in Oncology|March 8, 2021
Mutational Pattern in Multiple Pulmonary Nodules Are Associated With Early Stage Lung AdenocarcinomaShao-Wei Dong, Rong Li, Zhiqiang Cheng, et al.
Frontiers in Medicine|October 1, 2021
Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer PatientsJinan Guo, Xuhui Zhang, Taolin Xia, et al.
Frontiers in Oncology|August 9, 2020
WNT2-Mediated FZD2 Stabilization Regulates Esophageal Cancer Metastasis via STAT3 SignalingYufei Fu, Qi Zheng, Yingying Mao, et al.
BMC Medicine|December 1, 2020
Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-upHeather Johnson, Jinan Guo, Xuhui Zhang, et al.
Frontiers in Pharmacology|March 18, 2020
METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung CancerDongcheng Liu, Wei Li, Fuhua Zhong, et al.
Clinical and Translational Medicine|March 30, 2021
A 23-Gene Classifier urine test for prostate cancer prognosisJinan Guo, Heather Johnson, Xuhui Zhang, et al.
The Journal of Experimental Medicine|May 27, 2020
Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolismQingxin Zhou, Meihua Lin, Xing Feng, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 5, 2024
A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesisJinan Guo, Xiaoshi Ma, Dongcheng Liu, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Molecular Cancer|October 9, 2020
Identification of a distinct luminal subgroup diagnosing and stratifying early stage prostate cancer by tissue-based single-cell RNA sequencingXiaoshi Ma, Jinan Guo, Kaisheng Liu, et al.
Molecular Cancer|July 19, 2017
FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancerShucai Yang, Yi Liu, Ming-Yue Li, et al.
Frontiers in Oncology|March 8, 2021
Mutational Pattern in Multiple Pulmonary Nodules Are Associated With Early Stage Lung AdenocarcinomaShao-Wei Dong, Rong Li, Zhiqiang Cheng, et al.
Frontiers in Medicine|October 1, 2021
Non-invasive Urine Test for Molecular Classification of Clinical Significance in Newly Diagnosed Prostate Cancer PatientsJinan Guo, Xuhui Zhang, Taolin Xia, et al.
Frontiers in Oncology|August 9, 2020
WNT2-Mediated FZD2 Stabilization Regulates Esophageal Cancer Metastasis via STAT3 SignalingYufei Fu, Qi Zheng, Yingying Mao, et al.
BMC Medicine|December 1, 2020
Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-upHeather Johnson, Jinan Guo, Xuhui Zhang, et al.
Frontiers in Pharmacology|March 18, 2020
METTL7B Is Required for Cancer Cell Proliferation and Tumorigenesis in Non-Small Cell Lung CancerDongcheng Liu, Wei Li, Fuhua Zhong, et al.
Clinical and Translational Medicine|March 30, 2021
A 23-Gene Classifier urine test for prostate cancer prognosisJinan Guo, Heather Johnson, Xuhui Zhang, et al.
The Journal of Experimental Medicine|May 27, 2020
Targeting CLK3 inhibits the progression of cholangiocarcinoma by reprogramming nucleotide metabolismQingxin Zhou, Meihua Lin, Xing Feng, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 5, 2024
A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesisJinan Guo, Xiaoshi Ma, Dongcheng Liu, et al.
Pageof 20